Takeda Asks Fed. Circ. To Undo Trintellix IP Loss
By Britain Eakin ( March 23, 2022, 6:55 PM EDT) -- Takeda Pharmaceuticals has asked the Federal Circuit to undo a decision — made by a former federal judge who just took a seat on the appeals court — that a slew of generic-drug makers don't infringe two of its patents on antidepressant drug Trintellix....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.